Literature DB >> 24577250

Changes in cytokines in tears after endoscopic endonasal dacryocystorhinostomy for primary acquired nasolacrimal duct obstruction.

J K Lee1, T H Kim1.   

Abstract

PURPOSE: We attempted to compare the cytokine composition of tears between primary acquired nasolacrimal duct (NLD) obstruction and normal controls. We investigated the changes in cytokines in tears after endoscopic endonasal dacryocystorhinostomy (DCR). PATIENTS AND METHODS: Eighteen patients underwent endonasal DCR, with seven patients undergoing bilateral DCR, resulting in twenty-five DCRs in total. Eleven contralateral un-operated eyes were used as normal controls. Silicone stents were removed 3 months after surgery. Tear samples were collected from all eyes before surgery, and at 1 month, 2 months, 3 months, and 4 months after surgery. The level of interleukin (IL)-1β, IL-2, IL-6, IL-10, transforming growth factor (TGF)-β2, fibroblast growth factor (FGF)-2, and vascular endothelial growth factor (VEGF) in the tears was measured.
RESULTS: The concentrations of IL-2, IL-6, IL-10, VEGF, and FGF-2 were significantly higher in eyes with NLD obstruction than controls before surgery (P=0.006, 0.018, 0.002, 0.048, and 0.039, respectively). Most inflammatory cytokines (IL-1β, IL-2, IL-6, VEGF, and FGF-2) were higher in the tears of the DCR group compared with the controls during the postoperative follow-up, but then rapidly decreased to the level of the controls after removal of the silicone stent. The recurred eyes showed a higher level of TGF-β2 and FGF-2 in tears compared with the eyes that showed good surgical results (P<0.005 and <0.005, respectively).
CONCLUSION: The tear levels of inflammatory cytokines were higher in eyes with NLD obstruction than controls. The changes in cytokine level during the postoperative period showed the importance of cytokine analysis in understanding wound healing after DCR.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24577250      PMCID: PMC4017116          DOI: 10.1038/eye.2014.33

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  40 in total

1.  Tear fluid gelatinase B activity correlates with IL-1alpha concentration and fluorescein clearance in ocular rosacea.

Authors:  A A Afonso; L Sobrin; D C Monroy; M Selzer; B Lokeshwar; S C Pflugfelder
Journal:  Invest Ophthalmol Vis Sci       Date:  1999-10       Impact factor: 4.799

2.  Primary acquired nasolacrimal duct obstruction. A clinicopathologic report and biopsy technique.

Authors:  J V Linberg; S A McCormick
Journal:  Ophthalmology       Date:  1986-08       Impact factor: 12.079

3.  TGF-beta1 regulates TGF-beta1 and FGF-2 mRNA expression during fibroblast wound healing.

Authors:  Q H Song; V E Klepeis; M A Nugent; V Trinkaus-Randall
Journal:  Mol Pathol       Date:  2002-06

4.  Effects of the silicone tube on the canaliculus: an animal experiment.

Authors:  J W Snead; J E Rathbun; J B Crawford
Journal:  Ophthalmology       Date:  1980-10       Impact factor: 12.079

5.  A clinical trial of endoscopic vs external dacryocystorhinostomy for partial nasolacrimal duct obstruction.

Authors:  F H Zaidi; S Symanski; J M Olver
Journal:  Eye (Lond)       Date:  2011-07-22       Impact factor: 3.775

6.  The change of cytokines in tear and blood after different pterygium operation.

Authors:  Jeong Kyu Lee; Young Soo Song; Jun Seop Shin; Young Sam Kwon; Mi Sun Shin; Jae Chan Kim
Journal:  Cytokine       Date:  2009-12-08       Impact factor: 3.861

7.  Tear cytokine and chemokine analysis and clinical correlations in evaporative-type dry eye disease.

Authors:  Amalia Enríquez-de-Salamanca; Evangelina Castellanos; Michael E Stern; Itziar Fernández; Ester Carreño; Carmen García-Vázquez; Jose M Herreras; Margarita Calonge
Journal:  Mol Vis       Date:  2010-05-19       Impact factor: 2.367

8.  Dacryocystorhinostomy failure: association with nasolacrimal silicone intubation.

Authors:  K Allen; A J Berlin
Journal:  Ophthalmic Surg       Date:  1989-07

9.  Factors affecting the success rate of open lacrimal surgery.

Authors:  M J Walland; G E Rose
Journal:  Br J Ophthalmol       Date:  1994-12       Impact factor: 4.638

10.  Use of mitomycin C in repeat dacryocystorhinostomy.

Authors:  R P Yeatts; R B Neves
Journal:  Ophthalmic Plast Reconstr Surg       Date:  1999-01       Impact factor: 1.746

View more
  7 in total

1.  Conjunctival cytologic features in patients with unilateral primary acquired nasolacrimal duct obstruction.

Authors:  Nilay Yuksel; Melek Mutlu; Aydan Kilicarslan; Emine Akcay
Journal:  Int Ophthalmol       Date:  2017-02-21       Impact factor: 2.031

2.  Detection & analysis of inflammatory cytokines in tears of patients with lacrimal duct obstruction.

Authors:  Dan Wang; Nan Xiang; Wei Kun Hu; Ban Luo; Xiang Tian Xiao; Yin Zhao; Bin Li; Rong Liu
Journal:  Indian J Med Res       Date:  2021-06       Impact factor: 5.274

3.  Clinical characteristics of lacrimal drainage pathway disease-associated keratopathy.

Authors:  Hidenori Inoue; Koji Toriyama; Wakako Ikegawa; Yukako Hiramatsu; Arisa Mitani; Yuki Takezawa; Yuri Sakane; Tomoyuki Kamao; Yuko Hara; Atsushi Shiraishi
Journal:  BMC Ophthalmol       Date:  2022-08-31       Impact factor: 2.086

Review 4.  Human Serum Eye Drops in Eye Alterations: An Insight and a Critical Analysis.

Authors:  Maria Rosaria De Pascale; Michele Lanza; Linda Sommese; Claudio Napoli
Journal:  J Ophthalmol       Date:  2015-10-04       Impact factor: 1.909

5.  Kinetic Profiles of Inflammatory Mediators in the Conjunctival Sac Fluid of Patients upon Photorefractive Keratectomy.

Authors:  Veronica Tisato; Paolo Perri; Erika Rimondi; Elisabetta Melloni; Giuseppe Lamberti; Daniela Milani; Paola Secchiero; Giorgio Zauli
Journal:  Mediators Inflamm       Date:  2015-10-07       Impact factor: 4.711

Review 6.  The Use of Stents in Children with Nasolacrimal Duct Obstruction Requiring Surgical Intervention: A Systematic Review.

Authors:  Evelyn Li Min Tai; Yee Cheng Kueh; Baharudin Abdullah
Journal:  Int J Environ Res Public Health       Date:  2020-02-07       Impact factor: 3.390

7.  Rebamipide promotes lacrimal duct epithelial cell survival via protecting barrier function.

Authors:  Hiroshi Tanaka; Tomomichi Nakayama; Michiko Tsukamoto; Akihide Watanabe; Takahiro Nakamura; Norihiko Yokoi; Chie Sotozono; Shigeru Kinoshita
Journal:  Sci Rep       Date:  2020-02-03       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.